The average one-year price target for INVO Fertility (NasdaqCM:IVF) has been revised to $146.88 / share. This is an increase of 700.00% from the prior estimate of $18.36 dated November 14, 2025. The ...

In-vitro fertilization (IVF) can take a serious toll on families, not only emotionally but financially, especially when every cycle comes with new bills and no clear sense of what the full journey ...

) has been revised to $146.88 / share. This is an increase of 700.00% from the prior estimate of $18.36 dated November 14, 2025. The price target is an average of many targets provided by analysts.

INVO Fertility Inc. (“INVO” or the “Company”) (NASDAQ: IVF), a healthcare company focused on the fertility market, today announced it has entered into a warrant inducement agreement with an investor ( ...

Australians battling infertility face being slugged with huge increases for IVF depending on what clinic they choose, with ...